Generic Drug Policies in Latin America
The World Health Organization and pharmaceutical experts have recommended that Generic Drug Policies be implemented to improve the availability of affordable medicines. This document reports on the status of generic drug policies in Latin America....
| Main Authors: | , , |
|---|---|
| Format: | Working Paper |
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2013
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2005/03/5734957/generic-drug-policies-latin-america http://hdl.handle.net/10986/13639 |
| id |
okr-10986-13639 |
|---|---|
| recordtype |
oai_dc |
| spelling |
okr-10986-136392021-04-23T14:03:09Z Generic Drug Policies in Latin America Homedes, Núria López Linares, Roberto Ugalde, Antonio ACCESS TO PHARMACEUTICALS ACTIVE INGREDIENTS BIOEQUIVALENCE BRAND NAME BRAND NAME DRUGS BRAND NAMES BRANDED GENERIC DRUGS CLINICAL TRIALS COMMERCIALIZATION COUNTERFEIT DRUGS DRUG MANUFACTURING DRUG POLICIES DRUG POLICY DRUG PRICES ESSENTIAL DRUGS GENERIC DRUGS GENERIC PRODUCTS GENERIC SUBSTITUTION GMP GOOD MANUFACTURING PRACTICES HEALTH CARE HEALTH POLICY HEALTH SERVICES HOSPITALS HUMAN DEVELOPMENT LABORATORIES LATIN AMERICAN LAWS LOCAL PRODUCTION MARKET VALUE MEDICINE MEDICINES NATIONAL DRUG POLICIES NEW PRODUCT DEVELOPMENT NUTRITION PATIENTS PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURING PHARMACEUTICAL POLICIES PHARMACEUTICAL POLICY PHARMACEUTICAL PRODUCTION PHARMACEUTICAL PRODUCTS PHARMACEUTICAL REGISTRATION PHARMACEUTICALS PHARMACISTS PHARMACOLOGY PHARMACY PHYSICIANS POLICY DOCUMENTS PRESCRIPTIONS PRICE CONTROLS PRIVATE SECTOR PROCUREMENT PUBLIC HEALTH PUBLIC SECTOR QUALITY QUALITY ASSURANCE RETAIL SAFETY SALES STRATEGIC PLANNING SUPPLIERS The World Health Organization and pharmaceutical experts have recommended that Generic Drug Policies be implemented to improve the availability of affordable medicines. This document reports on the status of generic drug policies in Latin America. The data presented are based on several sources: a survey conducted in 2003, archival information, and official health and pharmaceutical policy documents. The survey revealed that countries use different definitions for the terms generic and bioequivalence severely curtailing the ability to make comparisons across countries. There is also ample variability in the periods allowed for drug registration and registration charges. Although most countries in the region are becoming increasingly dependent on pharmaceutical imports, many have sizeable local pharmaceutical manufacturing capacity. The need to adopt common definitions for technical terms, the urgency of improving quality controls and the importance of strengthening generic drug programs are highlighted. 2013-05-29T17:51:59Z 2013-05-29T17:51:59Z 2005-03 http://documents.worldbank.org/curated/en/2005/03/5734957/generic-drug-policies-latin-america http://hdl.handle.net/10986/13639 English en_US Health, Nutrition and Population (HNP) discussion paper; CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/ World Bank World Bank, Washington, DC Publications & Research :: Working Paper Publications & Research Latin America & Caribbean Latin America |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English en_US |
| topic |
ACCESS TO PHARMACEUTICALS ACTIVE INGREDIENTS BIOEQUIVALENCE BRAND NAME BRAND NAME DRUGS BRAND NAMES BRANDED GENERIC DRUGS CLINICAL TRIALS COMMERCIALIZATION COUNTERFEIT DRUGS DRUG MANUFACTURING DRUG POLICIES DRUG POLICY DRUG PRICES ESSENTIAL DRUGS GENERIC DRUGS GENERIC PRODUCTS GENERIC SUBSTITUTION GMP GOOD MANUFACTURING PRACTICES HEALTH CARE HEALTH POLICY HEALTH SERVICES HOSPITALS HUMAN DEVELOPMENT LABORATORIES LATIN AMERICAN LAWS LOCAL PRODUCTION MARKET VALUE MEDICINE MEDICINES NATIONAL DRUG POLICIES NEW PRODUCT DEVELOPMENT NUTRITION PATIENTS PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURING PHARMACEUTICAL POLICIES PHARMACEUTICAL POLICY PHARMACEUTICAL PRODUCTION PHARMACEUTICAL PRODUCTS PHARMACEUTICAL REGISTRATION PHARMACEUTICALS PHARMACISTS PHARMACOLOGY PHARMACY PHYSICIANS POLICY DOCUMENTS PRESCRIPTIONS PRICE CONTROLS PRIVATE SECTOR PROCUREMENT PUBLIC HEALTH PUBLIC SECTOR QUALITY QUALITY ASSURANCE RETAIL SAFETY SALES STRATEGIC PLANNING SUPPLIERS |
| spellingShingle |
ACCESS TO PHARMACEUTICALS ACTIVE INGREDIENTS BIOEQUIVALENCE BRAND NAME BRAND NAME DRUGS BRAND NAMES BRANDED GENERIC DRUGS CLINICAL TRIALS COMMERCIALIZATION COUNTERFEIT DRUGS DRUG MANUFACTURING DRUG POLICIES DRUG POLICY DRUG PRICES ESSENTIAL DRUGS GENERIC DRUGS GENERIC PRODUCTS GENERIC SUBSTITUTION GMP GOOD MANUFACTURING PRACTICES HEALTH CARE HEALTH POLICY HEALTH SERVICES HOSPITALS HUMAN DEVELOPMENT LABORATORIES LATIN AMERICAN LAWS LOCAL PRODUCTION MARKET VALUE MEDICINE MEDICINES NATIONAL DRUG POLICIES NEW PRODUCT DEVELOPMENT NUTRITION PATIENTS PHARMACEUTICAL INDUSTRY PHARMACEUTICAL MANUFACTURING PHARMACEUTICAL POLICIES PHARMACEUTICAL POLICY PHARMACEUTICAL PRODUCTION PHARMACEUTICAL PRODUCTS PHARMACEUTICAL REGISTRATION PHARMACEUTICALS PHARMACISTS PHARMACOLOGY PHARMACY PHYSICIANS POLICY DOCUMENTS PRESCRIPTIONS PRICE CONTROLS PRIVATE SECTOR PROCUREMENT PUBLIC HEALTH PUBLIC SECTOR QUALITY QUALITY ASSURANCE RETAIL SAFETY SALES STRATEGIC PLANNING SUPPLIERS Homedes, Núria López Linares, Roberto Ugalde, Antonio Generic Drug Policies in Latin America |
| geographic_facet |
Latin America & Caribbean Latin America |
| relation |
Health, Nutrition and Population (HNP)
discussion paper; |
| description |
The World Health Organization and
pharmaceutical experts have recommended that Generic Drug
Policies be implemented to improve the availability of
affordable medicines. This document reports on the status of
generic drug policies in Latin America. The data presented
are based on several sources: a survey conducted in 2003,
archival information, and official health and pharmaceutical
policy documents. The survey revealed that countries use
different definitions for the terms generic and
bioequivalence severely curtailing the ability to make
comparisons across countries. There is also ample
variability in the periods allowed for drug registration and
registration charges. Although most countries in the region
are becoming increasingly dependent on pharmaceutical
imports, many have sizeable local pharmaceutical
manufacturing capacity. The need to adopt common definitions
for technical terms, the urgency of improving quality
controls and the importance of strengthening generic drug
programs are highlighted. |
| format |
Publications & Research :: Working Paper |
| author |
Homedes, Núria López Linares, Roberto Ugalde, Antonio |
| author_facet |
Homedes, Núria López Linares, Roberto Ugalde, Antonio |
| author_sort |
Homedes, Núria |
| title |
Generic Drug Policies in Latin America |
| title_short |
Generic Drug Policies in Latin America |
| title_full |
Generic Drug Policies in Latin America |
| title_fullStr |
Generic Drug Policies in Latin America |
| title_full_unstemmed |
Generic Drug Policies in Latin America |
| title_sort |
generic drug policies in latin america |
| publisher |
World Bank, Washington, DC |
| publishDate |
2013 |
| url |
http://documents.worldbank.org/curated/en/2005/03/5734957/generic-drug-policies-latin-america http://hdl.handle.net/10986/13639 |
| _version_ |
1764423945229959168 |